Melanoma has a hereditary component, but most cases are not inherited. An estimated 5% to 10% of all melanoma cases occur in families with a clear genetic pattern. The remaining 90% to 95% are considered sporadic, meaning they develop from a combination of UV exposure, skin type, and random genetic changes rather than an inherited mutation passed from parent to child.
That said, even without a specific gene mutation, having a close relative with melanoma nearly doubles your risk. Understanding the difference between carrying a known melanoma gene and simply having a family history helps clarify what your actual risk looks like and what you can do about it.
Family History vs. a Genetic Mutation
These two concepts overlap but aren’t the same thing. A family history of melanoma means one or more of your blood relatives have been diagnosed. A hereditary melanoma mutation means a specific, identifiable change in a gene was passed down through your family that raises cancer risk. You can have a strong family history without anyone carrying a known mutation, and you can carry a mutation without anyone in your family having been diagnosed yet.
First-degree relatives (parents, siblings, children) of someone with melanoma have roughly a 92% increased risk of developing it themselves compared to the general population. That’s close to double the baseline risk. This elevated risk reflects shared genetics, shared skin type, and often shared sun exposure habits growing up. The more relatives affected, and the younger they were at diagnosis, the more likely a hereditary gene mutation is involved.
The Main Genes Involved
The most well-studied gene linked to hereditary melanoma is called CDKN2A. It acts as a tumor suppressor, essentially a brake on cell growth. When you inherit a faulty version, cells in the skin can divide more freely, raising cancer risk. Carriers of a CDKN2A mutation have a lifetime melanoma risk of 28% to 76%, depending on where they live and how much sun exposure they get. The wide range reflects how much environment still matters even when genetics load the dice. In a population-based study (rather than families already known to have many melanoma cases), the risk was about 14% by age 50 and 28% by age 80.
CDKN2A mutations also raise the risk of pancreatic cancer, with carriers facing a 10% to 15% lifetime risk. This connection means families with hereditary melanoma sometimes see pancreatic cancer appearing in the family tree as well.
Several other genes carry moderate to high melanoma risk:
- CDK4 works alongside CDKN2A in controlling cell division. Mutations are rare but carry similar risk levels.
- BAP1 mutations raise risk for melanoma along with kidney cancer and a type of eye cancer called uveal melanoma.
- POT1 helps protect the ends of chromosomes. Mutations here are linked to melanoma and other cancers.
- MITF carries a well-established moderate risk variant for melanoma.
Researchers believe that many familial melanoma cases may be driven by mutations in genes that haven’t been identified yet, or by combinations of low-penetrance gene variants that each contribute a small amount of risk.
The Red Hair Gene and Sun Exposure
A gene called MC1R plays a major role in determining skin and hair pigment. Certain variants of MC1R are responsible for red hair, fair skin, and freckling. These variants independently raise melanoma risk because they affect how well your skin defends itself against UV damage.
What makes MC1R especially interesting is how it interacts with sun exposure. Research from the GEM study found that people without MC1R risk variants who spent significant time in beach and water activities had nearly double the melanoma risk, while those with the variants had a smaller (though still elevated) increase from the same activities. For melanomas on the head and neck, the interaction was even more dramatic: people without MC1R variants who had high lifetime UV exposure saw risk multiply by more than 14 times, while carriers of MC1R variants showed much smaller increases from the same exposure levels.
This seems counterintuitive at first. The explanation is that MC1R variant carriers already have a high baseline risk from their skin type alone, so the added effect of UV is proportionally less dramatic. People with more protective pigmentation start from a lower baseline, meaning UV exposure creates a steeper climb in risk. The practical takeaway: sun protection matters for everyone, but the genetics of your skin color influence exactly how UV exposure shapes your personal risk.
Familial Atypical Multiple Mole Melanoma Syndrome
FAMMM syndrome is the most recognized hereditary melanoma condition. It’s diagnosed clinically based on three features: a high total body mole count (usually more than 50, sometimes in the hundreds), the presence of atypical moles that can resemble early melanoma, and a family history of melanoma in at least one first- or second-degree relative.
Atypical moles in FAMMM are evaluated using the same ABCDE criteria dermatologists use for any suspicious lesion: asymmetric shape, irregular borders, color variation within a single mole, diameter larger than 6 millimeters, and evolution or change over time. Having a few atypical moles is common in the general population, but having dozens alongside a family history of melanoma is a different situation entirely. Many people with FAMMM carry CDKN2A mutations, though the syndrome can be present without a detectable mutation.
When Genetic Testing Makes Sense
Genetic testing for melanoma susceptibility genes isn’t recommended for everyone who gets a melanoma diagnosis. It becomes relevant when the pattern suggests something hereditary is at play. Key signals include multiple melanomas in the same person, melanoma diagnosed at a young age, or multiple family members across generations affected by melanoma or pancreatic cancer.
Current guidelines from the American Society of Clinical Oncology recommend that all cancer patients have a detailed family history recorded, including cancers in first- and second-degree relatives. When that history raises red flags, multigene panel testing covering CDKN2A, CDK4, BAP1, POT1, and other relevant genes can be offered. Sometimes a mutation is found incidentally during tumor testing done for treatment purposes. In those cases, confirmatory germline testing (a blood or saliva test checking the DNA you were born with) is recommended regardless of family history.
Genetic testing results change what happens next in concrete ways. A positive result doesn’t just affect the person tested. It means siblings, children, and other relatives may also carry the mutation and could benefit from earlier, more intensive screening.
Surveillance for High-Risk Individuals
If you carry a known melanoma susceptibility gene or have a strong family history, surveillance protocols are more intensive than standard skin checks. For CDKN2A carriers, current recommendations include comprehensive skin examinations by a dermatologist every six months, using tools like total body photography and digital dermoscopy to track changes in moles over time. Some protocols suggest exams every three months for the highest-risk individuals.
Screening starts early. For CDKN2A carriers, clinical skin exams are recommended beginning at age 10, with monthly self-examination taught during childhood. This early start reflects the fact that hereditary melanoma tends to appear at younger ages than sporadic cases.
For other gene mutations, the schedules vary. BAP1 carriers are typically recommended for full skin exams every six months starting at age 18, plus imaging of the chest and abdomen every two years beginning at age 30 (because BAP1 mutations raise the risk of internal cancers). POT1 carriers generally follow annual dermatology visits with additional imaging.
A study of 311 high-risk patients monitored every six months with total body photography and digital mole tracking showed improved detection of melanomas that developed after their initial evaluation. These technologies allow dermatologists to compare images over time, catching subtle changes that would be nearly impossible to spot with the naked eye, particularly in someone with hundreds of moles.
What This Means if Melanoma Runs in Your Family
Having a parent or sibling with melanoma does not mean you will develop it. It means your risk is higher than average, and that regular skin checks carry more weight for you than for the general population. If multiple relatives have had melanoma, especially before age 50, or if pancreatic cancer also appears in your family, the chance of an underlying genetic mutation is higher and worth investigating.
Regardless of genetic status, the modifiable part of the equation remains significant. UV exposure is the dominant environmental driver, and it interacts with inherited risk rather than operating independently. Protective habits like limiting intense sun exposure (particularly in childhood and adolescence), using sunscreen, and avoiding tanning beds reduce risk across all genetic backgrounds. For those with hereditary susceptibility, these habits are especially impactful because the genetic vulnerability amplifies the damage UV can cause.